Publication Name	World Journal of Hepatology
Manuscript ID	99209
Country	Japan

Received	2024-08-22 06:28
Peer-Review Started	2024-07-17 09:20
To Make the First Decision
Return for Revision	2024-11-18 09:24
Revised	2024-11-21 10:49
Second Decision	2024-12-17 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-17 08:30
Articles in Press	2024-12-17 08:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-12-23 00:47
Publish the Manuscript Online	2025-01-06 08:47

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Hepatitis B virus infection and its treatment in Eastern Ethiopia
Manuscript Source	Invited Manuscript
All Author List	Tatsuo Kanda, Reina Sasaki-Tanaka, Atsunori Tsuchiya and Shuji Terai
ORCID	Author(s) ORCID Number Tatsuo Kanda http://orcid.org/0009-0000-8135-342X Reina Sasaki-Tanaka http://orcid.org/0000-0003-2681-0776 Atsunori Tsuchiya http://orcid.org/0000-0002-9279-5917 Shuji Terai http://orcid.org/0000-0002-5439-635X
Funding Agency and Grant Number
Corresponding Author	Tatsuo Kanda, MD, PhD, Professor, Division of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, 4132 Urasa, Minamiuonuma 949-7302, Niigata, Japan. kandatatsuo@gmail.com
Key Words	Antivirals; Ethiopia; Hepatitis B virus; Liver cirrhosis; Vaccines
Core Tip	To eliminate hepatitis B virus (HBV) infection worldwide by 2030, it is important to determine the actual status of HBV infection in Ethiopia, whose population was estimated 12300000 persons in 2022. At least 10.5% of blood samples from patients in Ethiopia were positive for the HBV surface antigen. In Eastern Ethiopia, HBV surface antigen-positive patients with cirrhosis appeared to be HBV e antigen-positive and had a higher viral load. Tenofovir disoproxil fumarate is effective for the suppression of HBV DNA in these patients. HBV vaccination and the educational programs for Health Science students that provide practical strategies could also reduce HBV infection in Eastern Ethiopia.
Publish Date	2025-01-06 08:47
Citation	<p>Kanda T, Sasaki-Tanaka R, Tsuchiya A, Terai S. Hepatitis B virus infection and its treatment in Eastern Ethiopia. <i>World J Hepatol</i> 2025; 17(1): 99209</p>
URL	https://www.wjgnet.com/1948-5182/full/v17/i1/99209.htm
DOI	https://dx.doi.org/10.4254/wjh.v17.i1.99209

Full Article (PDF)	WJH-17-99209-with-cover.pdf
Manuscript File	99209_Auto_Edited_083112.docx
Answering Reviewers	99209-answering-reviewers.pdf
Audio Core Tip	99209-audio.m4a
Conflict-of-Interest Disclosure Form	99209-conflict-of-interest-statement.pdf
Copyright License Agreement	99209-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99209-non-native-speakers.pdf
Peer-review Report	99209-peer-reviews.pdf
Scientific Misconduct Check	99209-scientific-misconduct-check.png
Scientific Editor Work List	99209-scientific-editor-work-list.pdf
CrossCheck Report	99209-crosscheck-report.pdf